Valuation: Supergenics

Market Cap 29.11M 7.12M 6.26M 5.82M 5.34M 10.01M 687M 10.2M 69.16M 26.99M 337M 26.72M 26.14M 1.17B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 7.95M 6.99M 6.5M 5.97M 11.18M 767M 11.39M 77.23M 30.14M 376M 29.83M 29.19M 1.3B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-04-23
Corporate Secretary - 2022-06-01
Director TitleAgeSince
Director/Board Member 48 2019-04-23
Director/Board Member 60 2019-04-23
Director/Board Member 46 2022-01-27
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+13.64% 7.11M
+1.07%-3.49%-3.25%+12.87% 46.86B
+0.25%+1.65%+399.22%+634.87% 40.23B
-0.27%+4.45%+11.81%+65.64% 36.23B
+0.35%+0.87%+4.46%-10.16% 34.72B
+3.14%+1.02%+3.37%+38.15% 27.89B
-0.73%+11.84%+34.39%+134.36% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%-3.43%+9.03% 13.12B
-2.68%-2.49%-11.36%-33.61% 12.7B
Average +2.40%+1.91%+46.50%+96.09% 24.53B
Weighted average by Cap. +0.48%+2.02%+74.26%+136.43%

Financials

2024 2025
Net sales 5.32M 1.3M 1.14M 1.06M 977K 1.83M 126M 1.86M 12.65M 4.93M 61.6M 4.88M 4.78M 213M 5.63M 1.38M 1.21M 1.12M 1.03M 1.94M 133M 1.97M 13.37M 5.22M 65.11M 5.16M 5.05M 225M
Net income -7.28M -1.78M -1.57M -1.46M -1.34M -2.5M -172M -2.55M -17.3M -6.75M -84.28M -6.68M -6.54M -292M -3.37M -823K -724K -673K -618K -1.16M -79.47M -1.18M -8M -3.12M -38.96M -3.09M -3.02M -135M
Net Debt 4.48M 1.09M 963K 895K 822K 1.54M 106M 1.57M 10.64M 4.15M 51.82M 4.11M 4.02M 179M 3.39M 830K 730K 679K 623K 1.17M 80.14M 1.19M 8.06M 3.15M 39.29M 3.12M 3.05M 136M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock